Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2209 ARTÍCULOS , VIENDO DEL 616 AL 630

Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?

Caselli RJ.

Pediatr Blood Cancer. 2014 Oct;61(10):1739-42. doi: 10.1002/pbc.24768. Epub 2013 Sep 17.

Function and dysfunction of presenilin

Shen J.

Neurodegener Dis. 2014;13(2-3):61-3. doi: 10.1159/000354971. Epub 2013 Oct 2.

What causes alzheimer's disease?

Armstrong RA.

Folia Neuropathol. 2013;51(3):169-88. doi: 10.5114/fn.2013.37702.

Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies

Swomley AM, Förster S, Keeney JT, Triplett J, Zhang Z, Sultana R, Butterfield DA.

Biochim Biophys Acta. 2014 Aug;1842(8):1248-57. doi: 10.1016/j.bbadis.2013.09.015. Epub 2013 Oct 9.

Awake bruxism in a patient with Alzheimer's dementia

Lai MM.

Geriatr Gerontol Int. 2013 Oct;13(4):1076-7. doi: 10.1111/ggi.12086.

Aggravation of Alzheimer's disease symptoms after the earthquake in Japan: A comparative analysis of subcategories

Furukawa K, Ootsuki M, Nitta A, Okinaga S, Kodama M, Arai H.

Geriatr Gerontol Int. 2013 Oct;13(4):1081-2. doi: 10.1111/ggi.12085.

[Epigenetic mechanisms of Alzheimer's disease and related drug research]

Gong HC, Wang YL, Wang HW.

Yao Xue Xue Bao. 2013 Jul;48(7):1005-13.

The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes

Bekkering P, Jafri I, van Overveld FJ, Rijkers GT.

Expert Rev Clin Immunol. 2013 Nov;9(11):1031-41. doi: 10.1586/1744666X.2013.848793. Epub 2013 Oct 21.

Alzheimer disease and cognitive impairment associated with diabetes mellitus type 2: associations and a hypothesis

Domínguez RO, Pagano MA, Marschoff ER, González SE, Repetto MG, Serra JA.

Neurologia. 2014 Nov-Dec;29(9):567-72. doi: 10.1016/j.nrl.2013.05.006. Epub 2013 Oct 18.

Transcriptional regulation and its misregulation in Alzheimer's disease

Chen XF, Zhang YW, Xu H, Bu G.

Mol Brain. 2013 Oct 21;6:44. doi: 10.1186/1756-6606-6-44.

Afferent and efferent immunological pathways of the brain. Anatomy, function and failure

Carare RO, Hawkes CA, Weller RO.

Brain Behav Immun. 2014 Feb;36:9-14. doi: 10.1016/j.bbi.2013.10.012. Epub 2013 Oct 18.

Current concepts in Alzheimer's Disease: molecules, models and translational perspectives

Rutten BP, Steinbusch HW.

Mol Neurodegener. 2013 Oct 22;8:33. doi: 10.1186/1750-1326-8-33.

Blood-brain-barriers in aging and in Alzheimer's disease

Marques F, Sousa JC, Sousa N, Palha JA.

Mol Neurodegener. 2013 Oct 22;8:38. doi: 10.1186/1750-1326-8-38.

Epigenetics of Alzheimer's disease and frontotemporal dementia

Veerappan CS, Sleiman S, Coppola G.

Neurotherapeutics. 2013 Oct;10(4):709-21. doi: 10.1007/s13311-013-0219-0.

The influence of nutritional supplement drinks on providing adequate calorie and protein intake in older adults with dementia

Allen V, Methven L, Gosney M.

J Nutr Health Aging. 2013 Sep;17(9):752-5. doi: 10.1007/s12603-013-0364-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias